Literature DB >> 10881133

[Evaluation of an specific treatment for Trypanosoma cruzi in children, in the evolution of the indeterminate phase].

C A Silveira1, E Castillo, C Castro.   

Abstract

Twelve chagasic patients between the ages of seven and twelve, in the indeterminate phase with serology and xenodiagnosis positive, received the specific treatment. Eight of these were evaluated after an eight-year treatment period and four were followed-up during 20 years. Two patients took 7 mg/kg of nifurtimox during sixty and ninety days and ten of these used 5-7 mg/kg of benznidazole during 60 days. The clinical outcome was verified through clinical examination, electrocardiogram and contrasted X-ray of the esophagus. After the treatment, only one patient presented negativity in all the examinations. Seven (58.4%) remained in the indeterminate form and despite the precocious treatment four chagasic patients (33.3%) progressed clinically to second degree cardiopathy and/or megaesophagus.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10881133     DOI: 10.1590/s0037-86822000000200006

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  6 in total

Review 1.  Pathogenesis of chagas' disease: parasite persistence and autoimmunity.

Authors:  Antonio R L Teixeira; Mariana M Hecht; Maria C Guimaro; Alessandro O Sousa; Nadjar Nitz
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

Review 2.  Trypanocidal drugs for chronic asymptomatic Trypanosoma cruzi infection.

Authors:  Juan Carlos Villar; Juan Guillermo Perez; Olga Lucia Cortes; Adelina Riarte; Micah Pepper; Jose Antonio Marin-Neto; Gordon H Guyatt
Journal:  Cochrane Database Syst Rev       Date:  2014-05-27

3.  Changing Epidemiology and Approaches to Therapy for Chagas Disease.

Authors:  Louis V. Kirchhoff
Journal:  Curr Infect Dis Rep       Date:  2003-02       Impact factor: 3.725

Review 4.  Course of Chronic Trypanosoma cruzi Infection after Treatment Based on Parasitological and Serological Tests: A Systematic Review of Follow-Up Studies.

Authors:  Yanina Sguassero; Cristina B Cuesta; Karen N Roberts; Elizabeth Hicks; Daniel Comandé; Agustín Ciapponi; Sergio Sosa-Estani
Journal:  PLoS One       Date:  2015-10-05       Impact factor: 3.240

Review 5.  Course of serological tests in treated subjects with chronic Trypanosoma cruzi infection: A systematic review and meta-analysis of individual participant data.

Authors:  Yanina Sguassero; Karen N Roberts; Guillermina B Harvey; Daniel Comandé; Agustín Ciapponi; Cristina B Cuesta; Camila Aguiar; Ana M de Castro; Emmaría Danesi; Ana L de Andrade; Marta de Lana; Josep M Escribà; Diana L Fabbro; Cloé D Fernandes; María Flores-Chávez; Alejandro M Hasslocher-Moreno; Yves Jackson; Carlos D Lacunza; Girley F Machado-de-Assis; Marisel Maldonado; Wendell S F Meira; Israel Molina; María M Monje-Rumi; Catalina Muñoz-San Martín; Laura Murcia; Cleudson Nery de Castro; Olga Sánchez Negrette; Manuel Segovia; Celeste A N Silveira; Aldo Solari; Mário Steindel; Mirtha L Streiger; Ninfa Vera de Bilbao; Inés Zulantay; Sergio Sosa-Estani
Journal:  Int J Infect Dis       Date:  2018-06-04       Impact factor: 3.623

6.  Benznidazole and posaconazole in experimental Chagas disease: positive interaction in concomitant and sequential treatments.

Authors:  Lívia de Figueiredo Diniz; Julio A Urbina; Isabel Mayer de Andrade; Ana Lia Mazzeti; Tassiane Assíria F Martins; Ivo Santana Caldas; André Talvani; Isabela Ribeiro; Maria Terezinha Bahia
Journal:  PLoS Negl Trop Dis       Date:  2013-08-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.